Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

June 15, 2012 (Vol. 32, No. 12)

Proposed Standards for Immunogenicity Testing

USP Seeks Input on Recently Introduced Set of Best Practices for ADA Screening Activities

  • Biologic drugs have revolutionized the treatment of many chronic diseases. Used to treat certain cancers, autoimmune diseases like multiple sclerosis, and several other complex disorders, many modern biologic drugs are essentially proteins in their makeup—either naturally derived, derived from recombinant technology or, in some cases, chemically synthesized. Protein ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.